MEDICOX Co., Ltd. Logo

MEDICOX Co., Ltd.

Manufactures shipbuilding materials and equipment, and develops biopharmaceuticals.

054180 | KO

Overview

Corporate Details

ISIN(s):
KR7054180005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도산대로 549 2~3층 (청담동, 블루펄빌딩), 강남구

Description

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-05-12 00:00
의결권대리행사권유참고서류
Korean 45.0 KB
2022-05-11 00:00
주요사항보고서(감자결정)
Korean 13.4 KB
2022-05-11 00:00
주권매매거래정지(자본감소)
Korean 4.7 KB
2022-05-11 00:00
[기재정정]주주총회소집결의
Korean 17.6 KB
2022-05-11 00:00
주주총회소집공고
Korean 123.6 KB
2022-05-10 00:00
주식등의대량보유상황보고서(약식)
Korean 71.6 KB
2022-05-10 00:00
[기재정정]기타경영사항(자율공시)(만기전 취득한 제15회, 제16회 전환사채 재매각)
Korean 17.2 KB
2022-05-04 00:00
전환가액의조정(제17회차)
Korean 12.5 KB
2022-04-28 00:00
[기재정정]기타경영사항(자율공시)(만기전 취득한 제15회, 제16회 전환사채 재매각)
Korean 16.3 KB
2022-04-28 00:00
전환가액의조정(제15회차)
Korean 11.2 KB
2022-04-26 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 67.8 KB
2022-04-20 00:00
증권발행결과(자율공시)(제18회차 CB)
Korean 6.5 KB
2022-04-20 00:00
전환가액의조정(제16회차)
Korean 12.5 KB
2022-04-13 00:00
[기재정정]기타경영사항(자율공시)(만기전 취득한 제15회, 제16회 전환사채 재매각)
Korean 15.8 KB
2022-04-11 00:00
주주총회소집결의
Korean 6.5 KB

Automate Your Workflow. Get a real-time feed of all MEDICOX Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MEDICOX Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MEDICOX Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.